BEAM
Price
$18.30
Change
-$0.40 (-2.14%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
1.89B
96 days until earnings call
CDXS
Price
$2.86
Change
-$0.07 (-2.39%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
242.74M
7 days until earnings call
Interact to see
Advertisement

BEAM vs CDXS

Header iconBEAM vs CDXS Comparison
Open Charts BEAM vs CDXSBanner chart's image
Beam Therapeutics
Price$18.30
Change-$0.40 (-2.14%)
Volume$58.07K
Capitalization1.89B
Codexis
Price$2.86
Change-$0.07 (-2.39%)
Volume$12.9K
Capitalization242.74M
BEAM vs CDXS Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CDXS commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CDXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (BEAM: $18.70 vs. CDXS: $2.93)
Brand notoriety: BEAM and CDXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 165% vs. CDXS: 122%
Market capitalization -- BEAM: $1.89B vs. CDXS: $242.74M
BEAM [@Biotechnology] is valued at $1.89B. CDXS’s [@Biotechnology] market capitalization is $242.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCDXS’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CDXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and CDXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while CDXS’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • CDXS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CDXS.

Price Growth

BEAM (@Biotechnology) experienced а -6.17% price change this week, while CDXS (@Biotechnology) price change was +3.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.67%. For the same industry, the average monthly price growth was +14.79%, and the average quarterly price growth was +13.41%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CDXS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.89B) has a higher market cap than CDXS($243M). BEAM YTD gains are higher at: -24.597 vs. CDXS (-38.574). CDXS has higher annual earnings (EBITDA): -62.28M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CDXS (59.8M). CDXS has less debt than BEAM: CDXS (59.5M) vs BEAM (158M). BEAM has higher revenues than CDXS: BEAM (63.6M) vs CDXS (49.8M).
BEAMCDXSBEAM / CDXS
Capitalization1.89B243M779%
EBITDA-399.03M-62.28M641%
Gain YTD-24.597-38.57464%
P/E RatioN/AN/A-
Revenue63.6M49.8M128%
Total Cash1.22B59.8M2,040%
Total Debt158M59.5M266%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCDXS
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGRCX29.40N/A
N/A
Invesco Comstock Select C
MSVZX9.06N/A
N/A
MassMutual Small Company Val I
HAITX57.72N/A
N/A
Hartford Core Equity R6
LGCRX18.94N/A
N/A
Lord Abbett Global Equity R3
FPKFX16.91N/A
N/A
Fidelity Puritan K6